#Switzerland #Zurich #Antimicrobial Technology #Polaroid Therapeutics #POLTX_Fiber™

Polaroid Therapeutics Launches POLTX_Fiber™: A New Standard in Wound Care

Polaroid Therapeutics (PTx) recently made headlines with the announcement that their innovative product, POLTX_Fiber™, has achieved the prestigious CE Mark as a Class IIb medical device. This exciting development signifies PTx’s entry into the competitive wound care market, setting the stage for advanced wound management solutions using their pioneering Antimicrobial Polymer Technology (APT™).

A Game-Changer for Wound Care

The POLTX_Fiber™ is a pioneering antimicrobial gelling fiber dressing made with sodium carboxymethyl cellulose (CMC) and cellulose fibers that are finely designed to integrate APT™. The role of APT™ is crucial; it actively prevents bacterial colonization without contributing to antimicrobial resistance, a growing concern within the medical field. By forming a gel upon contact with wound exudate, this dressing creates a moist environment ideal for wound healing, enhancing conditions for autolytic debridement, and protecting the wound edge and surrounding skin.

This versatile dressing is suitable for various types of wounds, including:

• - Moderate to heavy exudate wounds
• - Acute and chronic wounds
• - Leg ulcers and pressure ulcers (stage II to IV)
• - Diabetic ulcers
• - Surgical wounds
• - Traumatic wounds like abrasions and lacerations
• - Exuding oncology wounds
• - Both superficial and cavity wounds

Commitment to Innovation

Ran Frenkel, Co-founder and CEO of PTx, remarked on the significance of receiving the CE Mark: "This milestone underscores our ambition to deliver enhanced care options for patients through innovative, human-centric solutions built on robust technology and scientific development. POLTX_Fiber™ is not just another medical device; it's at the forefront of a new era in wound care, leveraging our APT™ platform to meet the real challenges faced by clinicians today."

What sets POLTX_Fiber™ apart from traditional wound dressings is its method of action. Unlike many antimicrobial products that release their active components and can lead to side effects, APT™ integrates these functionalities into the structure of the dressing itself. This design ensures rapid action while maintaining sustained antimicrobial efficacy, effectively reducing risks associated with bacterial colonization.

Market Rollout and Future Directions

With the CE Mark in hand, PTx is eager to introduce POLTX_Fiber™ into select European markets. The company is actively collaborating with clinicians, wound care centers, and distribution partners to initiate clinical trials and gather patient feedback, which will be invaluable as they expand their market presence.

Moreover, POLTX_Fiber™ marks just the beginning of PTx’s APT™-powered product line. Plans are already in motion to develop additional medical devices that will leverage this innovative platform, broadening the scope of wound care applications. This strategic development aims to ensure that patients have access to the best possible treatments for their healing needs.

About Polaroid Therapeutics

Established in 2022, Polaroid Therapeutics is a Swiss biotech startup focused on creating impactful antimicrobial technologies. Born from the legacy of Polaroid, known for revolutionizing photography with its innovative technology, PTx aims to apply the same spirit of innovation to the medical field, addressing the ever-evolving challenges in healthcare.

Through rigorous research and development, PTx has crafted their unique APT™ platform, engineered to provide controlled antimicrobial performance through innovative structural designs rather than chemical releases. This commitment reflects PTx's dedication to responsible innovation, solid scientific evidence, and long-term stewardship against antimicrobial resistance.

POLTX_Fiber™ exemplifies their vision—a high-quality wound dressing produced under ISO 13485 standards, ensuring safety and efficacy in medical environments. As they embark on this journey into wound care, Polaroid Therapeutics is poised to redefine standards and outcomes in the healthcare landscape.